Edition:
United Kingdom

People: Regeneron Pharmaceuticals Inc (REGN.OQ)

REGN.OQ on NASDAQ Stock Exchange Global Select Market

389.83USD
19 Oct 2018
Change (% chg)

$-5.39 (-1.36%)
Prev Close
$395.22
Open
$396.58
Day's High
$399.84
Day's Low
$387.84
Volume
287,494
Avg. Vol
278,661
52-wk High
$442.80
52-wk Low
$281.89

Van Plew, Daniel 

Mr. Daniel P. Van Plew is an Executive Vice President, General Manager - Industrial Operations and Product Supply of the Company. Mr. Van Plew served as Senior Vice President and General Manager, Industrial Operations and Product Supply. Prior to that date, he served as Vice President and General Manager, Industrial Operations and Product Supply since joining the Company in 2007. From 2006 until 2007, Mr. Van Plew served as Executive Vice President, R&D and Technical Operations of Crucell Holland B.V., a global biopharmaceutical company. Between 2004 and 2006, Mr. Van Plew held positions of increasing responsibility at Chiron Biopharmaceuticals, part of Chiron Corporation, a biotechnology company, most recently as Senior Director, Vacaville Operations. From 1998 until 2004, Mr. Van Plew held various managerial positions in the health and life sciences practice at Accenture, Ltd., a management consulting business. Mr. Van Plew received his M.S. in Chemistry from The Pennsylvania State University and his M.B.A. from Michigan State University.

Basic Compensation

Total Annual Compensation, USD 560,000
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 8,418,600
Fiscal Year Total, USD 8,978,600

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

P. Roy Vagelos

11,825,400

Leonard Schleifer

26,508,100

Robert Landry

4,794,740

Daniel Van Plew

8,978,600

Neil Stahl

9,137,220

Joseph LaRosa

--
As Of  31 Dec 2017